Abeona Therapeutics to present at major healthcare investor conferences in June 2026

Abeona Therapeutics announced its management team will participate in the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. The company will hold a fireside chat and investor meetings, with a live webcast available for the Jefferies event. Abeona is a biopharmaceutical company focused on cell and gene therapies, including its commercial product ZEVASKYN for treating wounds in patients with recessive dystrophic epidermolysis bullosa. These conferences provide Abeona an opportunity to update investors on its progress and pipeline developments.